Issue Information ‐ Author Checklist
8 September 2021
Magnetic resonance elastography plus Fibrosis‐4 versus FibroScan–aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH‐related fibrosis
Nobuharu Tamaki, Kento Imajo, Suzanne Sharpton, Jinho Jung, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajima, Rohit Loomba – 7 September 2021
More Than Meets the Eye?
Ying Claire Dorsey, Omobonike Oloruntoba, Avani A. Pendse, Lindsay Y. King – 7 September 2021
Research methodologies to address clinical unmet needs and challenges in alcohol‐associated liver disease
Ashwani K. Singal, Paul Kwo, Allison Kwong, Suthat Liangpunsakul, Alexandre Louvet, Pranoti Mandrekar, Craig McClain, Jessica Mellinger, Gyongyi Szabo, Norah Terrault, Mark Thursz, Gerald S. Winder, W. Ray Kim, Vijay H. Shah – 7 September 2021 – Alcohol‐associated liver disease (ALD) is emerging worldwide as the leading cause of liver‐related morbidity, mortality, and indication for liver transplantation.
Optimizing hepatitis B virus screening in the United States using a simple demographics‐based model
Nathan S. Ramrakhiani, Vincent L. Chen, Michael Le, Yee Hui Yeo, Scott D. Barnett, Akbar K. Waljee, Ji Zhu, Mindie H. Nguyen – 7 September 2021
With Alcohol as the Fuel, COVID Is the Match: Liver Transplantation for Alcohol‐Associated Liver Disease Is Increasing in the United States
Patricia P. Bloom, Robert J. Fontana – 7 September 2021
A Simple Bacterium Links Heart Infection to Inflammatory Liver Disease
Pierre Isnard, Marion Larue, Aurelia Pitsch, Jean‐Paul Duong Van Huyen, Philippe Seksik, Loic Brot, Sylvain Diamantis, Julie Bruneau, Maxence Rouyer – 7 September 2021
More Than Meets the Eye?
Ying Claire Dorsey, Omobonike Oloruntoba, Avani A. Pendse, Lindsay Y. King – 7 September 2021
Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling
Mar Coll, Silvia Ariño, Celia Martínez‐Sánchez, Ester Garcia‐Pras, Javier Gallego, Anna Moles, Beatriz Aguilar‐Bravo, Delia Blaya, Julia Vallverdú, Teresa Rubio‐Tomás, Juan Jose Lozano, Elisa Pose, Isabel Graupera, Andrea Fernández‐Vidal, Albert Pol, Ramón Bataller, Jian‐Guo Geng, Pere Ginès, Mercedes Fernandez, Pau Sancho‐Bru – 6 September 2021
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis
Pascale Gluais‐Dagorn, Marc Foretz, Gregory R. Steinberg, Battsetseg Batchuluun, Anna Zawistowska‐Deniziak, Joost M. Lambooij, Bruno Guigas, David Carling, Pierre‐Axel Monternier, David E. Moller, Sebastien Bolze, Sophie Hallakou‐Bozec – 6 September 2021 – No approved therapies are available for nonalcoholic steatohepatitis (NASH). Adenosine monophosphate–activated protein kinase (AMPK) is a central regulator of cell metabolism; its activation has been suggested as a therapeutic approach to NASH.